Riskpilot← Back to searchSign inGet full accessHälsokonsult Celcus AB
ABActiveOrg 5566035696Brandliljegatan 14Hospital activities · NACE 8610Est. 20012 employees
Revenue 2025
SEK 2,6M
-16% vs 2024
EBITDA margin
36.3%
+7% vs 2024
Equity ratio
76.0%
Financial strength
Net profit 2025
SEK 1,1M
+53% vs 2024
| Revenue | SEK 2,6M | -16% |
| EBITDA | SEK 935K | +7% |
| Net profit | SEK 1,1M | +53% |
| Total assets | SEK 7,9M | +8% |
| Equity | SEK 6M | +23% |
| Employees | 2 | — |
Legal name
Hälsokonsult Celcus AB
Org number
5566035696
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
3 januari 2001
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall driva sjuk- och hälsovård, uthyrning av personal inom hälsovårdssektorn, forskning och utbildningsverkamhet inom sjuk- och hälsovårdsområdet. Bolaget skall även kunna äga och förvalta fastigheter och värdepapper samt idka därmed förenlig verksamhet. Bolaget skall även bedriva travhästverksamhet.
Address
Brandliljegatan 14
Email
pabergsten@live.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 921 | 3 813 | 3 025 | 3 082 | 2 578 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 995 | 1 839 | 1 687 | 871 | 935 |
| Depreciation & amort. | −65 | −72 | −78 | −82 | −70 |
| EBIT | 1 930 | 1 767 | 1 609 | 789 | 865 |
| Net financials | −7 | −51 | −2 | −46 | 64 |
| Profit before tax | 1 419 | 1 315 | 1 307 | 943 | 1 428 |
| Tax | −305 | −276 | −279 | −213 | −308 |
| Net profit | 1 114 | 1 039 | 1 028 | 730 | 1 120 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 348 | 6 609 | 7 359 | 7 344 | 7 938 |
| Equity | 3 163 | 3 803 | 4 831 | 4 911 | 6 032 |
| Long-term debt | 107 | 326 | 36 | 76 | 90 |
| Short-term debt | 578 | 580 | 292 | 356 | 316 |
| Total debt | 685 | 906 | 328 | 432 | 406 |
EBITDA margin
36.3%
This company
15.8%
Market median
+130% vs market
20212025
Equity ratio
76.0%
This company
38.2%
Market median
+99% vs market
20212025
Return on equity
18.6%
This company
18.4%
Market median
+1% vs market
20212025
Net profit margin
43.4%
This company
8.1%
Market median
+436% vs market
20212025
Asset turnover
0.32×
This company
1.12×
Market median
-71% vs market
20212025
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hälsokonsult Celcus AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pa Fenix Bergsten | Board of Directors | 0 companies |
| Erica J M Johansson Bergsten | Deputy Board Member | 0 companies |
| Ida Maria Matilda Bergsten | Deputy Board Member | 0 companies |